BRCA2 and breast cancer: Based on the above results, we can conclude that ER-positive BC have a worse prognosis than ER-negative BC in BRCA2-mutated patients and BRCA2-mutated BC have a worse prognosis than non-BRCA2-mutated BC in ER-positive patients.